Franciscan Missionaries of Our Lady Health System
Questions or Suggestions
Drug Information Questions
Search by name
Search by class
Show Therapeutic Classes
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Black Box Warning
Do Not Crush
REMS
Therapeutic Interchange
Do Not Tube-LALK
Do Not Tube-LACH
Restricted
CMS Self-Administered Drug Exclusion List
Look Alike Sound Alike Drugs
FMOLHS Rhazdrugs
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
News
Boards
*COVID-19 Pharmacy Resources
Franciscan Missionaries of Our Lady Health System
Questions or Suggestions
Drug Information Questions
Search by name
Additional search options
Search by class
Show Therapeutic Classes
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Black Box Warning
Do Not Crush
REMS
Therapeutic Interchange
Do Not Tube-LALK
Do Not Tube-LACH
Restricted
CMS Self-Administered Drug Exclusion List
Look Alike Sound Alike Drugs
FMOLHS Rhazdrugs
Search results for:
divalproex sodium
divalproex sodium
Brand names:
Divalproex Sodium ER, Divalproex Sodium Sprinkles
Form
Strength
ANAN
ASMP
LACH
LALK
LOHH
LOLR
LOWC
SDSD
SESE
SFSF
Formulary Status
DELAYED RELEASE CAPSULE, ORAL
125 mg
DELAYED RELEASE TABLET, ORAL
125 mg; 250 mg; 500 mg
TABLET, EXTENDED RELEASE, ORAL
250 mg; 500 mg
VIEW MORE
Anticonvulsants, Miscellaneous
CLASS
281292
Last updated:
Nov. 30, 2021
Black Box Warning:
Hepatotoxicity; mitochondrial disease; fetal risk
Do Not Crush:
Slow-release (b) Capsule - Note: mucous membrane irritant
Do Not Crush:
Delayed-release Tablet
Do Not Crush:
Extended-release Tablet
Do Not Crush:
Extended-release (a) Capsule
UpToDate
FDA Package Inserts
Acadiana Market Specific P&T Updates
Jackson Market Specific P&T Updates
UpToDate Lexidrug